Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all‐cause mortality in individuals with type 2 diabetes in the ADVANCE trial

Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes

(2019) Toshiaki Ohkuma et al.   Clinical Journal of the American Society of Nephrology

The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study

(2019) Megumi Oshima et al.   DIABETOLOGIA

Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

(2019) Andrew S. Levey et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease

(2019) Jennifer S. Lees et al.   NATURE MEDICINE

Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes

(2018) Katherine G. Garlo et al.   Clinical Journal of the American Society of Nephrology

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

(2018) Paul K. Whelton et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019

(2018)   DIABETES CARE

GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD

(2016) Lesley A. Inker et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study

(2016) Meredith C. Foster et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis

(2016) Lesley A. Inker et al.   Clinical Journal of the American Society of Nephrology

Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON

(2016) Muh Geot Wong et al.   DIABETES CARE

Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014

(2016) Maryam Afkarian et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Filtration Markers as Predictors of ESRD and Mortality in Southwestern American Indians With Type 2 Diabetes

(2015) Meredith C. Foster et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Change in Novel Filtration Markers and Risk of ESRD

(2015) Casey M. Rebholz et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality

(2015) C. M. Rebholz et al.   Clinical Journal of the American Society of Nephrology

The Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation does not improve the underestimation of Glomerular Filtration Rate (GFR) in people with diabetes and preserved renal function

(2015) Richard J. MacIsaac et al.   BMC Nephrology

Novel Filtration Markers as Predictors of All-Cause and Cardiovascular Mortality in US Adults

(2013) Meredith C. Foster et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate, Vascular Disease, and Mortality in Persons With Diabetes in the U.S.

(2013) Ching-Wei Tsai et al.   DIABETES CARE

Novel Markers of Kidney Function as Predictors of ESRD, Cardiovascular Disease, and Mortality in the General Population

(2012) Brad C. Astor et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

(2012)   AMERICAN JOURNAL OF KIDNEY DISEASES

Clinical Utility of Creatinine- and Cystatin C-Based Definition of Renal Function for Risk Prediction of Primary Cardiovascular Events in Patients With Diabetes

(2012) B. Schottker et al.   DIABETES CARE

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

(2012) Caroline S Fox et al.   LANCET

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C

(2012) Lesley A. Inker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Measured GFR, Serum Creatinine, Cystatin C, and Beta-Trace Protein to Predict ESRD in African Americans With Hypertensive CKD

(2011) Nrupen A. Bhavsar et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Equation Pronouncedly Underestimates Glomerular Filtration Rate in Type 2 Diabetes

(2011) S. P. Silveiro et al.   DIABETES CARE

Filtration Markers May Have Prognostic Value Independent of Glomerular Filtration Rate

(2011) N. Tangri et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function

(2011) Frank A. Holtkamp et al.   KIDNEY INTERNATIONAL

The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is less accurate in patients with Type 2 diabetes when compared with healthy individuals

(2010) E. G. Camargo et al.   DIABETIC MEDICINE

Cystatin C, Albuminuria, and Mortality Among Older Adults With Diabetes

(2009) I. H. de Boer et al.   DIABETES CARE

Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

(2009) T. Ninomiya et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE